IT-DEX and B cell depletion in a child with anti-GAD 65 autoimmune encephalitis presenting as NORSE: A case report

被引:0
作者
Yarimi, Jonathan M. [1 ,2 ]
Sandweiss, Alexander J. [1 ,2 ]
Salazar, Karla P. [1 ,2 ]
Massrey, Chrissie [1 ,2 ]
Ankar, Alexander [1 ,2 ]
Muscal, Eyal [3 ,4 ]
Lai, Yi-Chen [5 ]
Cokley, Jon A. [6 ]
Davila-Williams, Daniel [1 ,2 ]
Shukla, Nikita M. [1 ,2 ]
Fisher, Kristen S. [1 ,2 ]
机构
[1] Baylor Coll Med, Dept Pediat, Div Pediat Neurol & Dev Neurosci, 6701 Fannin St,Ste 1250, Houston, TX 70030 USA
[2] Texas Childrens Hosp, 6701 Fannin St,Ste 1250, Houston, TX 70030 USA
[3] Baylor Coll Med, Dept Pediat, Sect Rheumatol, 6701 Fannin St, Houston, TX 70030 USA
[4] Texas Childrens Hosp, 6701 Fannin St, Houston, TX 70030 USA
[5] Texas Childrens Hosp, Dept Pediat, Div Pediat Crit Care Med, Baylor Coll Med, 6701 Fannin St, Houston, TX 70030 USA
[6] Texas Childrens Hosp, Dept Pharm, 6701 Fannin St, Houston, TX 70030 USA
关键词
New-onset refractory status epilepticus; Glutamic acid decarboxylase antibody; Autoimmune encephalitis; Intrathecal dexamethasone; Cytokines;
D O I
10.1016/j.jneuroim.2024.578430
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
New-onset refractory status epilepticus (NORSE) is a devastating clinical condition that often leads to severe disability. Intrathecal dexamethasone (IT-DEX) has been reported to improve refractory status epilepticus. We present an 11-year-old female with anti-GAD 65 encephalitis presenting as NORSE who had minimal response to standard anti-seizure medications and first-line immunotherapies. The patient received 6 doses of IT-DEX in conjunction with rituximab which correlated with subsequent decreased neuroinflammation, reduced seizure burden and aided in weaning anesthetic infusions. Our case with literature review suggests IT-DEX may be utilized as an early intervention in those with refractory status epilepticus from various etiologies.
引用
收藏
页数:4
相关论文
共 16 条
[1]   Antibody-Mediated Encephalitis [J].
Dalmau, Josep ;
Graus, Francesc .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (09) :840-851
[2]   Intrathecal dexamethasone therapy for febrile infection-related epilepsy syndrome [J].
Horino, Asako ;
Kuki, Ichiro ;
Inoue, Takeshi ;
Nukui, Megumi ;
Okazaki, Shin ;
Kawawaki, Hisashi ;
Togawa, Masao ;
Amo, Kiyoko ;
Ishikawa, Junichi ;
Ujiro, Atsushi ;
Shiomi, Masashi ;
Sakuma, Hiroshi .
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2021, 8 (03) :645-655
[3]   Anti-inflammatory and immune-mediated therapy for a case of febrile infection-related epilepsy syndrome with rapid recurrence [J].
Kurimoto, Tomonori ;
Matsuoka, Tsuyoshi ;
Ami, Yuki ;
Kanno, Koji ;
Fujii, Takashi ;
Fujiwara, Naoki ;
Matsuoka, Takashi .
CLINICAL CASE REPORTS, 2022, 10 (06)
[4]   Intrathecal Dexamethasone in Febrile Infection-Related Epilepsy Syndrome [J].
Mehta, Niyati P. ;
Sawdy, Rachel ;
Maloney, Kathleen ;
Overlee, Brittany ;
Johnson, Renee K. ;
Howe, Charles L. ;
Farias-Moeller, Raquel .
NEUROLOGY-CLINICAL PRACTICE, 2023, 13 (03)
[5]   Neurologic syndromes related to anti-GAD65 Clinical and serologic response to treatment [J].
Munoz-Lopetegi, Amaia ;
de Bruijn, Marienke A. A. M. ;
Boukhrissi, Sanae ;
Bastiaansen, Anna E. M. ;
Nagtzaam, Mariska M. P. ;
Hulsenboom, Esther S. P. ;
Boon, Agnita J. W. ;
Neuteboom, Rinze F. ;
de Vries, Juna M. ;
Sillevis Smitt, Peter A. E. ;
Schreurs, Marco W. J. ;
Titulaer, Maarten J. .
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2020, 7 (03)
[6]   The influence of intrathecal injection of methotrexate and dexamethasone on neuropsychiatric systemic lupus erythematosus (NPSLE): a retrospective cohort study of 386 patients with NPSLE [J].
Nie, Yuxue ;
Sun, Boyuan ;
He, Xin ;
Zheng, Minmin ;
Wu, Di ;
Yang, Yunjiao ;
Zhang, Li ;
Bai, Wei ;
Jiang, Nan ;
Qiao, Lin ;
Huang, Can ;
Zhou, Shuang ;
Zhou, Jiaxin ;
Peng, Linyi ;
Niu, Jingwen ;
Li, Mengtao ;
Zhao, Yan ;
Zeng, Xiaofeng ;
Wang, Li ;
Zhang, Wen .
ARTHRITIS RESEARCH & THERAPY, 2023, 25 (01)
[7]   Use and Safety of Immunotherapeutic Management of N-Methyl-D-Aspartate Receptor Antibody Encephalitis A Meta-analysis [J].
Nosadini, Margherita ;
Eyre, Michael ;
Molteni, Erika ;
Thomas, Terrence ;
Irani, Sarosh R. ;
Dalmau, Josep ;
Dale, Russell C. ;
Lim, Ming .
JAMA NEUROLOGY, 2021, 78 (11) :1333-1344
[8]   Clinical presentation of new onset refractory status epilepticus in children (the pSERG cohort) [J].
Sculier, Claudine ;
Barcia Aguilar, Cristina ;
Gaspard, Nicolas ;
Gainza-Lein, Marina ;
Sanchez Fernandez, Ivan ;
Amengual-Gual, Marta ;
Anderson, Anne ;
Arya, Ravindra ;
Burrows, Brian T. ;
Brenton, James N. ;
Carpenter, Jessica L. ;
Chapman, Kevin E. ;
Clark, Justice ;
Gaillard, William D. ;
Glauser, Tracy A. ;
Goldstein, Joshua L. ;
Goodkin, Howard P. ;
Gorman, Mark ;
Lai, Yi-Chen ;
McDonough, Tiffani L. ;
Mikati, Mohamad A. ;
Nayak, Anuranjita ;
Peariso, Katrina ;
Riviello, James ;
Rusie, Allison ;
Sperberg, Katherine ;
Stredny, Coral M. ;
Tasker, Robert C. ;
Tchapyjnikov, Dmitry ;
Vasquez, Alejandra ;
Wainwright, Mark S. ;
Wilfong, Angus A. ;
Williams, Korwyn ;
Loddenkemper, Tobias .
EPILEPSIA, 2021, 62 (07) :1629-1642
[9]   Favorable response to classic ketogenic diet in a child with anti-GAD 65 antibody mediated super refractory status epilepticus [J].
Sivathanu, Deepika ;
Kewalramani, Deepti ;
Manokaran, Ranjith Kumar .
EPILEPSY & BEHAVIOR REPORTS, 2022, 19
[10]   Seizure burden and neuropsychological outcomes of new-onset refractory status epilepticus: Systematic review [J].
Taraschenko, Olga ;
Pavuluri, Spriha ;
Schmidt, Cynthia M. M. ;
Pulluru, Yashwanth Reddy ;
Gupta, Navnika .
FRONTIERS IN NEUROLOGY, 2023, 14